The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Young Richard A since 2012.
This trader's CIK number is 1490283.
At the time of last reporting, Young Richard A was the Director of Syros Pharmaceuticals, Inc.. (stock ticker symbol SYRS).
Also see all insider trading activities at Syros Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | SYRS | 0 | $0 | 0 | $0 | 2,666 | $0 |
2021 | SYRS | 0 | $0 | 7,500 | $94,087 | 0 | $0 |
2020 | SYRS | 0 | $0 | 65,890 | $630,900 | 0 | $0 |
2019 | SYRS | 0 | $0 | 25,000 | $250,000 | 0 | $0 |
2017 | SYRS | 0 | $0 | 6,564 | $144,700 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2012 | ENZN | 0 | $0 | 2,000 | $13,842 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | OMGA | 0 | $0 | 25,000 | $200,000 | 0 | $0 |
2022 | OMGA | 0 | $0 | 10,000 | $80,000 | 0 | $0 |
1. Syros Pharmaceuticals, Inc. (SYRS)
2. Enzon Pharmaceuticals, Inc. (ENZN)
3. Omega Therapeutics, Inc. (OMGA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-09-16 | SYRS | Option Ex | 2,666 | .00 | 0 |
2021-02-16 | SYRS | Sale | 3,750 | 12.05 | 45,187 |
2021-02-08 | SYRS | Sale | 3,750 | 13.04 | 48,900 |
2020-11-16 | SYRS | Sale | 633 | 8.98 | 5,684 |
2020-11-17 | SYRS | Sale | 5,357 | 8.75 | 46,873 |
2020-10-19 | SYRS | Sale | 5,673 | 8.75 | 49,638 |
2020-10-15 | SYRS | Sale | 317 | 8.75 | 2,773 |
2020-09-15 | SYRS | Sale | 5,990 | 10.39 | 62,236 |
2020-08-17 | SYRS | Sale | 5,990 | 12.59 | 75,414 |
2020-07-15 | SYRS | Sale | 5,990 | 11.85 | 70,981 |
2020-06-15 | SYRS | Sale | 5,990 | 8.75 | 52,412 |
2020-05-15 | SYRS | Sale | 5,990 | 9.22 | 55,239 |
2020-04-15 | SYRS | Sale | 23,960 | 8.75 | 209,650 |
2019-08-15 | SYRS | Sale | 2,300 | 10.00 | 23,000 |
2019-08-16 | SYRS | Sale | 22,700 | 10.00 | 227,000 |
2017-08-14 | SYRS | Sale | 3,282 | 22.00 | 72,204 |
2017-07-25 | SYRS | Sale | 3,282 | 22.09 | 72,496 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2012-03-15 | ENZN | Sale | 2,000 | 6.92 | 13,842 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-06-02 | OMGA | Sale | 5,000 | 8.00 | 40,000 |
2023-05-01 | OMGA | Sale | 5,000 | 8.00 | 40,000 |
2023-04-06 | OMGA | Sale | 5,000 | 8.00 | 40,000 |
2023-03-17 | OMGA | Sale | 10,000 | 8.00 | 80,000 |
2022-09-14 | OMGA | Sale | 10,000 | 8.00 | 80,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Young Richard A (Director of Syros Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.